Columbia University
New York, 10032, United States
Location status: Recruiting
NCT Number: NCT06741618
MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on strong preliminary work, the proposed research is the next logical step in a body of work designed to assess whether refinement of this mobile intervention used in combination with virtual PrEP Peer Navigation will result in improvements in PrEP uptake and a reduction in HIV-related behavior. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Interested in participating?
Request Info16 year–25 year
Male
Interventional
Not applicable
New York, 10032, United States
Location status: Recruiting
This study expands MyPEEPS Mobile to develop MyPEEPS Mobile Plus, a multi-level intervention comprised of MyPEEPS Mobile with added PrEP content (based upon expert advisory and youth feedback) + PrEP E-Peer Navigation to overcome the challenges of PrEP initiation, adherence, and persistence among YMSM. Peer navigation is an evidence-based, widely recommended intervention for reaching youth and MSM for HIV-related care outcomes, with evidence of acceptability among racial/ethnic minority YMSM for PrEP. Peer navigation addresses common reasons for failing to begin or maintain PrEP use, including low perceived risk, structural or logistic barriers to care engagement, and anticipated side effects. Relative to in-person and group-based HIV prevention programs, behavioral interventions with digital and virtual components can have vast reach and present unique potential to rapidly scale delivery to very large and hidden groups. Therefore, the investigators propose to conduct a randomized controlled trial to test the efficacy of MyPEEPS Mobile Plus (a multi-level intervention comprised of MyPEEPS Mobile + PrEP E-Peer Navigation) for promoting initiation, adherence, and persistence of PrEP and decreased HIV risk behavior in YMSM. Building upon the team's demonstrated ability to enroll large numbers of young racially and ethnically diverse YMSM and extensive experience developing mobile health interventions, the proposed study will test the efficacy of this expanded, multi-level mobile HIV prevention intervention emphasizing PrEP. If efficacious, it will increase PrEP initiation, adherence, and persistence and decrease overall HIV risk in diverse YMSM in the US.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An evidence-based, digitally delivered mHealth sexual risk reduction intervention on HIV incidence
Electronic peer navigation to PreP services
Time frame: Baseline, 6-month follow-up, 12-month follow-up
Participants will self-report attending at least one PrEP-related care visit to asess medical eligibility for PrEP initiation.
Time frame: Baseline, 6-month follow-up, 12-month follow-up
Daily oral PrEP users will report PrEP use in the past 7-days.
Time frame: Baseline, 6-month follow-up, 12-month follow-up
Questions will be measure visit constancy, i.e., self-report at least 1 PrEP related care visit in the past 6 months.
Contact information is provided by the study sponsor or research team.
Columbia University
Other
MyPEEPS Mobile Plus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07072481
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Yaba, Lagos, Nigeria
View Trial DetailsNCT06949774
Acquired Immunodeficiency Syndrome, Behavior
Kampala, Uganda
View Trial DetailsNCT05330923
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Beijing, Beijing Municipality, China
View Trial DetailsNCT04378439
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Winston-Salem, North Carolina, United States
View Trial Details